MedTrace Logo

Mucoderm® Versus CTG in the Treatment of Multiple Gingival Recessions Associated With Non-carious Cervical Lesion.

NCT03594513 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2020-05-01

No results posted yet for this study

Summary

The aim of the present study is to compare two different multidisciplinary protocols using two types of grafts, porcine acellular dermal matrix (Mucoderm®) versus connective tissue graft, both associated with modified coronally advanced flap, in the treatment of multiple adjacent gingival recessions associated with non-carious cervical lesion partially (NCCL) restored by composite resin.

Conditions

  • Gingival Recession
  • Tooth Abrasion

Interventions

PROCEDURE

MCAF

Periodontal surgical technique to treat gingival recessions.

PROCEDURE

PR

Restorative procedure to treat tooth structure loss.

PROCEDURE

CTG

Autogenous graft harvested from palate placed in the surgical site.

PROCEDURE

XMD(Mucoderm®)

Xenogenous graft placed in the surgical site.

DRUG

Sodium dipyrone

All participants were instructed to take 500 mg sodium dipyrone just in case of pain.

DRUG

chlorhexidine rinse

All participants were instructed to perform 0.12% chlorhexidine rinse after the surgical procedures.

Sponsors & Collaborators

  • Fundação de Amparo à Pesquisa do Estado de São Paulo

    collaborator OTHER_GOV

  • Universidade Estadual Paulista Júlio de Mesquita Filho

    lead OTHER

Principal Investigators

  • Mauro P Santamaria, PhD · ICT-UNESP

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-07-02
Primary Completion
2019-11-02
Completion
2020-08-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03594513 on ClinicalTrials.gov